FDA.reportPublic FDA data

Voydeya 100 MG Oral Tablet

RxCUI
2678967
RxNorm name
Voydeya 100 MG Oral Tablet
Display name
Voydeya 100 MG Oral Tablet
Full name
Voydeya 100 MG Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:15

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
VoydeyaDANICOPANAlexion Pharmaceuticals Inc.ab8d1cbd-a28b-4d49-82ab-5c7460719ac72026-05-12Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2678967

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
ab8d1cbd-a28b-4d49-82ab-5c7460719ac7Voydeya 100 MG Oral Tablet [PSN] · danicopan 100 MG Oral Tablet [Voydeya] [SBD] · Voydeya 100 MG Oral Tablet [SY]35These highlights do not include all the information needed to use VOYDEYA safely and effectively. See full prescribing information for VOYDEYA. VOYDEYA ® (danicopan) tablets, for oral use Initial U.S. Approval: 202420260512